BL
Insider
Baker Bros. Advisors Lp
OtherBaker Bros. Advisors Lp (Other) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 1 sale), most often in Kodiak Sciences Inc. (KOD). Across 7 priced purchase filings, the average 21-session return was +27.3% from execution and +5.7% from disclosure (delay-adjusted; derived). The largest single filing was $317.8M of CELC (3,100,000 sh across 2 lots, as filed), executed Jul 14. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+27.3%
avg across 7 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+5.7%
same 7 filings, from disclosure
Filings, ttm
10
9 buys · 1 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$765.6M
shares × price, as filed
Last traded
Nov 6
Filed Nov 6
Median ADV $129.9M across their filed names
Impact on $10,000 · 12M
$12,735 (+27.4%)
S&P 500 $10,907 (+9.1%) · 18.3 pts ahead
Baker Bros. Advisors Lp
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $519.9M
Sells $317.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
KODRecent filings
TRDAPURCHASE
Entrada Therapeutics, Inc.
View filing →
$240K26,468 sh across 2 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 4:09 PM ET TRDAPURCHASE Entrada Therapeutics, Inc. View filing → $1.0M
137,124 sh across 3 lots
Exec Nov 10 2025
Filed Nov 12 2025 · 5:34 PM ET CELCPURCHASE Celcuity Inc. View filing → $9.5M
169,712 sh across 3 lots
Exec Sep 8 2025
Filed Sep 10 2025 · 4:06 PM ET MDGLPURCHASE Madrigal Pharmaceuticals, Inc. View filing → $36.7M
96,519 sh across 22 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 6:12 PM ET MDGLPURCHASE Madrigal Pharmaceuticals, Inc. View filing → $24.5M
67,279 sh across 21 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 6:09 PM ET